AULBIO Research & Development
Leveraging our innovative technological capabilities, we are actively expanding strategic partnerships and licensing
collaborations with global pharmaceutical companies, positioning ourselves as a leader in the future bio-healthcare industry.
collaborations with global pharmaceutical companies, positioning ourselves as a leader in the future bio-healthcare industry.
Open Innovation
with AULBIO
with AULBIO
With our third-generation hybrid ExTenna platform
and smart manufacturing infrastructure,
we transform partners’ drug candidates into
world-class long-acting therapeutics.
CRDMO
and smart manufacturing infrastructure,
we transform partners’ drug candidates into
world-class long-acting therapeutics.
AULBIO News
-
AulBio Accelerates Preparation for KOSDAQ IPO as Long-Acting Injectable Specialist
2025.10.27
-
AulBio Appoints Cherng-Ju Kim as New CEO to Strengthen Technical Leadership and Accelerate KOSDAQ Listing Plans
2025.10.27
-
Joint development of a 1-month long-acting next-generation GLP-1 receptor agonist (RA) injectable
2025.10.27



